The latest news & stories from the Providence Research Network

Researchers develop framework for health systems to build bridges and engage Black, Latino and American Indian communities in medical research

An analysis supported by Providence CORE looks at the state of Oregon's birth doula workforce and factors that are helping or hindering efforts to grow and support it.

A targeted therapy being evaluated in a clinical trial may improve survival for high-risk patients with diffuse large B-cell lymphoma.

Marge received treatment for pancreatic cancer at Providence Cancer Institute and then volunteered in the infusion center to help the care team that supported her.

A new Providence study shows that alcohol use, diabetes and other comorbidities could be risk factors for early onset colorectal cancer among people younger than 45.

Providence, Microsoft Research, University of Washington unveil GigaTIME, an AI-powered pathology breakthrough set to transform cancer immunotherapy research

Over 100 leaders, researchers and others from Montana and the Pacific Northwest recently convened for the announcement of a pioneering rural health collaborative from Providence and the University of

Two recently published studies of Providence’s Geno4Me program highlight how our whole genome sequencing research is advancing the promise of genomic medicine for all.

Providence and the University of Montana are launching RESOLVE, a pioneering rural health collaborative to improve access and outcomes in rural and indigenous health care.

Logan Vincent, M.D., is the first female interventional cardiologist to perform a cutting-edge heart valve replacement through the neck.

A study by Providence CORE and Dr. Roberta Hunte offers lessons for health systems partnering with culturally specific programs to improve Black maternal health outcomes.

Celebrating World Cancer Day with a look at the work of Carlo Bifulco, M.D. as he helps lead advancements in AI-driven, accessible precision oncology at Providence Cancer Institute.

Providence Cancer Institute researchers share important cancer research at SITC annual meeting and receive recognition for their contributions to science.

Providence and Microsoft Research have developed an AI framework that could revolutionize clinical trials and bring new treatments into play quicker than before.

New studies at Providence Cancer Institute offer hope to patients with limited treatment options.

The award will help Providence Swedish researchers tackle one of the most pressing challenges in cancer care: matching the right patient to the right immunotherapy. Learn more.

Providence Cancer Institute leader joined experts in cancer research, policy and advocacy to discuss current challenges and the future of research.

A medication designed to block and break down the androgen receptor, a key driver of prostate cancer growth, is being evaluated in a clinical trial at Providence Cancer Institute.

In a paper published in the prestigious New England Journal of Medicine AI, researchers from Providence and Microsoft propose an AI framework that could accelerate biomedical discovery.